BusinessGeron Reports Imetelstat Presentations at American Society of Hematology Annual MeetingBy Nasdaq OMXDec 12, 2017, 12:30 PM UTC
BusinessGeron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic SyndromesBy Nasdaq OMXNov 20, 2017, 12:30 PM UTC
BusinessGeron Announces Presentations at American Society of Hematology Annual MeetingBy Nasdaq OMXNov 1, 2017, 1:05 PM UTC
BusinessGeron Reports Imetelstat Presentations at American Society of Hematology Annual MeetingBy Nasdaq OMXDec 6, 2016, 9:01 PM UTC
BusinessApellis Reports Positive Interim Results from Phase 1b Clinical Trials of APL-2 in PNHBy Nasdaq OMXDec 2, 2016, 1:00 PM UTC
BusinessApellis to Present Safety and Efficacy Data from Clinical Trials of APL-2 in PNH at December Scientific MeetingsBy Nasdaq OMXNov 21, 2016, 1:00 PM UTC
BusinessCRISPR Therapeutics Announces Two Presentations Demonstrating the Potential for CRISPR Gene Editing To Treat Sickle Cell Disease and β-ThalassemiaBy Nasdaq OMXNov 21, 2016, 1:00 PM UTC
BusinessGeron Announces Presentations at American Society of Hematology Annual MeetingBy Nasdaq OMXNov 3, 2016, 1:13 PM UTC
